Introduction
activity to be creatine kinase-BB (2) . The cause of the , cathodic location is assumed to be an elevated molecular In the last three years repeated reports have appeared on rf ^^ ^^ ßß as g ^ rf aeodatton atypical isoenzyme distribution of creatine kinase immunoglobulins G and A (5, 8) . At present there is | (EC. 2.7.3.2) (1) (2) (3) (4) (5) (6) (7) (8) . Electrophoretic investigations (3,4, no izab , e connection with uniform etiological 5,7) show an-enzyme activity located between creatine patients manifested a regularly detectable and anamnestically inexplicable increase in total creatine kinase activity. The creatine kinase-MB activity in the serum was usually higher than total activity after application of the immunoinhibition test (MERCK-1-TEST-CK-MB) , This observation led us to characterize the isoenzyme distribution in greater detail by further analytical methods, to define the substrate affinity in comparison with the other isoenzymes by kinetic investigations, and to determine the molecular weight by gel filtration.
Materials and Methods
The total creatine kinase activity was measured with a GSHactivated and -after the introduction of the N-acety Icy steine (NAC) recommended as an activator by the German Society for Clinical Chemistry (9) As a reference serum we used that of a patient with severe intoxication (total creatine kinase activity 7000 U/l, creatine kinase-MB fraction 0.04) enriched with the same amount of human creatine kinase-BB. The molecular weight was determined with calibration proteins (BOEHRINGER) by gel filtration (Sepharose-6B, column 600 X 25 mm, phosphate 50 mmol/1, pH 7,2 emission volume 85 ml). For the molecular weight determination we used 1 ml (400 U) of the serum of patient 1 (2nd fraction from the column chromatography).
Patients
Age, sex, and clinical diagnoses of the patients are listed in table 1,
The results of the enzyme activity determinations obtained by the various methods are listed in table 2. Analysis of the eluates of column chromatography by immunotitration yielded for the first fraction (= "creatine kinase-MM") a mixture of creatine kinase-MM and creatine kinase.BB and for the second fraction (= "creatine kinase-MB") only creatine kinase-BB (tab. 3). The electrophoretic studies on selected serum samples (patients 1, 2, 4, 5 and 6) showed in each case a single creatine kinase band which in contrast to the known isoenzyme distribution of the reference serum,· was located between creatine kinase-MM and creatine kinase-MB ( fig. 1 ).
The second fraction from the column chromatography yielded creatine kinase-BB with a sufficient activity. We compared the substrate affinities of creatine kinase-BB prepared and purified from human tissue (14) with that isolated by column chromatography from human serum. Coronary heart disease, subclinical diabetes mellitus, hyperlipoproteinemia type IV, inferior myocardial infarction May 5th 19771
Coronary heart disease, subclinical diabetes mellitus.
Combined mitral valve defect, stage III-IV, embolism into the ramus interventricularis anterior during cardiac catheterism May 25 th 1977.
Bronchial asthma
Coronary heart disease, diabetes mellitus, pneumonia.
Coronary heart disease, hypertension, hypercholesterolemia, anterior-wall myoeardial reinfarction June 18th, 1978. The differences in substrate affinities of both enzymes for creatine phosphate and adenosine diphosphate are presented in table 4.
A molecular weight of 250,000 Daltons was determined for the atypical creatine kinase-BB by gel filtration ( fig. 2 ). This value was reproducible both for the native serum and (14) for the second fraction from the column chromatography. A molecular weight of 85,000 Daltons was determined for creatine kinase-BB obtained from myometrial smooth muscle.
We were able to examine the serum samples from patient 1 over a period of 20 months. Creatine kinase-BB was detected regularly throughout this time, though the level of the activity varied. No creatine kinase-B activity was found with the immunoinhibition test in this patient's three children.
In patient 6 we were able to examine the serum samples shortly after an acute myocardial infarction (7 hours after the onset of pain) and to study them over 3 days at short intervals. The immunptitration confirmed creatine kinase-MB activity only during the acute-phase of infarction; no creatine kiriase-MB was detected in the convalescence period. Creatine kinase-BB was, however, found to be constant in all samples and in all phases.
Discussion
The atypical creatine kinase activity was studied by 4 different analytical methods (immunoinhibition, immunotitration, column chromatography, and electrophoresis) for its relationship to the known isoenzyme distribution pattern. The results obtained by each of the 4 methods are contradictory and could give rise to misinterpretations.
The immunoinhibition seems to show in all 6 patients an exceptionally high creatine kinase-MB content. However, after inhibition of the creatine kinase-M subunits, this method measures only the remaining creatine kinase^B subunit activity, regardless of whether this is to be attributed to creatine kinase--MB or creatine kinase-BB. In all the samples studied by immunotitration, however, the creatine kinase activity could be identified as due primarily to the isoenzyrne creatine kinase-BB. The use of Mercer's modification (13) of column chromatography also simulates a high creatine kinase-MB content. Specific testing of the eluates with immunotitration gave for the first fraction ("creatine kinase-MM") a mixture of creatine-kinase-MM and creatine kinase-BB, and for the second fraction ("creatine kinase-MB") only creatine kinase-BB. The atypical electrophoretic location -all the enzyme activity was located in one band between creatine kinase-MM and creatine kinase-MB -indicates a changed mobility of the variant creatine kinase activity. This altered mobility is also the reason that the column chromatography simulates "creatine kinase-MB" activity in the eluate with the high salt content.
The atypical migration of the enzyme activity is obviously due to its high molecular weight (M T = 250,000) compared to the molecular weight of native creatine kinase isoenzymes (M T = 80,000, (15, 16) (8) , this is also the case for 5 of the six reported patients. The alteredM/c/zae//s constants of the creatine kinase-BB enzyme thus could be explained by steric hindrance.
The total creatine kinase activities are as a rule elevated, but normal activities (see patient 6) do not exclude presence of creatine kinase-BB. Since on the whole elevated total creatine kinase activities motivate isoenzyme differentiation, the frequency of patients with this phenomenon may be greater than indicated by the patient material examined so far (Lang et al. (2) Until now the study of relatives (patient 1, see also I.e. (2)) has given no evidence for a familial-genetic disposition. With few exceptions (patient 4, see also I.e. (2,4) ), the patients involved are elderly (average age 66.4 years). The sex distribution shows a bias toward women, if the data from comparable studies (2, 4, 5, 6) are included (female:male = 31:8).
